← Back to Clinical Trials
Recruiting NCT02531893

NCT02531893 Psychological Treatments for Youth With Severe Irritability.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02531893
Status Recruiting
Phase —
Sponsor National Institute of Mental Health (NIMH)
Condition Irritability
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2015-11-17
Primary Completion 2028-05-08

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 17 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2015-11-17 with a primary completion date of 2028-05-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Background: When children have severe irritability and temper outbursts, they can be so cranky or angry that it leads to problems at home, in school, and with friends. This is called Disruptive Mood Dysregulation Disorder (DMDD) and there have been no psychological treatments developed specifically for children with this problem. Researchers think two forms of therapy, Cognitive Behavioral Therapy (CBT) and Interpretation Bias Training (IBT), might help children with DMDD. Objective: To test two whether IBT and CBT can decrease severe irritability in children and youth. Eligibility: Children 8-17 years old with DMDD. Their symptoms must have started before age 10. Design: Participants will be screened with a review of their symptoms. Parents and participants will answer questions. Participants can do only one or both of these treatments if they wish. Those who wish to do both will start with IBT. Participants who do CBT will have 12-16 weekly meetings of research talk therapy. A parent will participate in part of the sessions. Participants will talk about what makes them irritable and how it affects them. They may be put in situations that might make them annoyed or irritable. Participants will rate how intense their irritability is. Parents and participants will complete rating scales, questionnaires, and interviews. Participants will do practice activities at home. Participants doing IBT will have up to 14 sessions over 10 weeks. Participants will view 15 faces, one at a time, on a computer. They will choose if the face looks happy or angry on a computer. Sometimes the computer gives feedback. Participants will complete some sessions at the NIH and some at home. Participants and parents answer questions about their progress. ...

Eligibility Criteria

* INCLUSION CRITERIA: Inclusion criteria for both Interpretation Bias Training and Cognitive Behavioral Therapy Studies: 1. Age 8-17 years 2. Must be enrolled into NIMH DIRP protocol 02-M-0021, Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in children and youth. 3. Must meet DSM 5 diagnostic criteria for DMDD which are (for CBT, must meet lifetime history of either DMDD or one of two core DMDD criteria \[b or c\]): * Must meet all of the following: 1. Diagnosis must first be made between ages 6-18 years 2. Abnormal mood (specifically, anger and/or irritability), present at least half of the day most days, and of sufficient severity to be noticeable by people in the child s environment (e.g. parents, teachers, peers). 3. Compared to his/her peers, the child exhibits markedly increased reactivity to negative emotional stimuli that is manifest verbally or behaviorally. For example, the child responds to frustration with extended temper tantrums (inappropriate for age and/or precipitating event), verbal rages, and/or aggression toward people or property. Such events occur, on average, at least three times a week. * The symptoms in b and c above are currently present and have been present for at least 12 months without any symptom-free periods exceeding two months. * The onset of symptoms must be prior to age 10 years. * The symptoms are severe in at least one setting (e.g. violent outbursts, assaultiveness at home, school, or with peers). In addition, there are at least mild symptoms (verbal aggression) in a second setting. 4. Patients must be fluent in English 1. All instruments have not been validated in other languages. 2. Psychotherapy will be designed and conducted in English. 5. On the basis of record review and interviews with child and parent, the research team agrees that the child s response to his/her current treatment is no more than minimal (i.e. CGI-S of 3 or more). 6. Must have no planned changes in outpatient psychiatric treatment regimen, which can include psychotropic medications and/or psychotherapeutic interventions, two weeks prior to enrollment and throughout the three weeks of training and post-training assessment. EXCLUSION CRITERIA: Exclusion criteria both Interpretation Bias Training and Cognitive Behavioral Therapy Studies: 1. The individual exhibits any of these cardinal bipolar symptoms: 1. Elevated or expansive mood. 2. Grandiosity or inflated self-esteem. 3. Decreased need for sleep. 4. Increase in goal-directed activity (this can result in the excessive involvement in pleasurable activities that have a high potential for painful consequences). 5. A history of hypomanic or manic symptoms that occurred in distinct episodes lasting more than 1 day. 2. Meets DSM 5 criteria for schizophrenia, schizophreniform disorder, schizoaffective illness, Autism Spectrum Disorder, or posttraumatic stress disorder. 3. IQ\<70 4. The symptoms are due to the direct physiologic effects of a drug of abuse, or to a general medical or neurological condition. 5. Meets criteria for alcohol or substance abuse three months prior to enrollment. 6. Meets DSM 5 criteria for current major depressive disorder. The rationale for the exclusion of youth with MDD is because the two novel interventions being tested are contraindicated for those with major depressive disorder. However, there is no contraindication to participation for those with treated/resolved or remitted major depressive disorder; only those with a current diagnosis need to be excluded.

Contact & Investigator

Central Contact

Melissa A Brotman, Ph.D.

✉ melissa.brotman@nih.gov

📞 (301) 435-6645

Principal Investigator

Melissa A Brotman, Ph.D.

PRINCIPAL INVESTIGATOR

National Institute of Mental Health (NIMH)

Frequently Asked Questions

Who can join the NCT02531893 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 17 Years, studying Irritability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT02531893 currently recruiting?

Yes, NCT02531893 is actively recruiting participants. Contact the research team at melissa.brotman@nih.gov for enrollment information.

Where is the NCT02531893 trial being conducted?

This trial is being conducted at Bethesda, United States.

Who is sponsoring the NCT02531893 clinical trial?

NCT02531893 is sponsored by National Institute of Mental Health (NIMH). The principal investigator is Melissa A Brotman, Ph.D. at National Institute of Mental Health (NIMH). The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology